The need for venovenous bypass in liver transplantation  by Fonouni, Hamidreza et al.
REVIEW REVIEW
The need for venovenous bypass in liver transplantation
HAMIDREZA FONOUNI*, ARIANEB MEHRABI*, MEHRDAD SOLEIMANI,
SASCHA A. MU¨LLER, MARKUS W. BU¨CHLER & JAN SCHMIDT
Department of General, Visceral and Transplant Surgery, University of Heidelberg, Germany
Abstract
Since introduction of the conventional liver transplantation (CLTx) by Starzl, which was based on the resection of recipient
inferior vena cava (IVC) along the liver, the procedure has undergone several refinements. Successful use of venovenous
bypass (VVB) was first introduced by Shaw et al., although in recent decades there has been controversy regarding the
routine use of VVB during CLTx. With development of piggyback liver transplantation (PLTx), the use of caval clamping
and VVB is avoided, leading to fewer complications related to VVB. However, some authors still advocate VVB in PLTx.
The great diversity among centers in their use of VVB during CLTx, or even along the PLTx technique, has led to confusion
regarding the indication setting for VVB. For this reason, we present an overview of the use of VVB in CLTx, the target of
patients for whom VVB could be beneficial, and the needs assessment of VVB for patients undergoing PLTx. Recent studies
have shown that with the advancement of surgical skills, refinement of surgical techniques, and improvements in
anesthesiology, there are only limited indications for doing CLTx with VVB routinely. PLTx with preservation of IVC can
be performed in almost all primary transplants and in the majority of re-transplantations without the need for VVB.
Nevertheless, in a few selective cases with severe intra-operative hemodynamic instability, or with a failed test of transient
IVC occlusion, the application of VVB is still justifiable. These indications should be judged intra-operatively and the
decision is based on each center’s preference.
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Introduction
Conventional liver transplantation (CLTx) has under-
gone continual improvement since it was first per-
formed by Starzl in 1963 [1]. The technique includes
resection of the recipient’s inferior vena cava (IVC)
along the liver, clamping of the portal vein, and end-
to-end cavo-caval anastomosis. This technique yields
severe hemodynamic instability because of complete
cross-clamping of the IVC and a huge reduction of
cardiac preload, as well as congestion of the gut due to
portal clamping. Therefore, a need was felt for a
system that would maintain venous return to the heart
and decompress intestinal venous stasis. In this
regard, the necessity of using a bypass circuit was
first described by Moore in 1960 [2], and thereafter
an experimental temporary portocaval shunt com-
bined with a passive femoral-jugular venous bypass
system was developed [35]. Ever since that time,
different bypass systems have been applied, including
passive venous shunts [6] and the partial cardiopul-
monary bypass introduced by Calne et al. in 1979 to
keep the hemodynamic status stable [7]. In 1983,
Griffith et al. [8] introduced the first VVB system with
centrifugal force pump and heparin-bonded tubing.
The clinical efficacy of this technique was confirmed
one year later by Shaw et al., who showed an
improved hemodynamic stability, better perfusion of
vital organs such as kidney and intestine, decreased
need of blood transfusion, a longer anhepatic phase
allowing the surgical team more time for CLTx, and
improved short-term patient survival (91% vs. 73% in
non-bypass group) [912]. With this technique, the
blood flow was withdrawn from portal and femoral
veins and returned to the central circulation via
axillary or subclavian veins. In the course of time,
the technique has undergone some improvements,
including the use of single-limb bypass (caval) instead
of double-limb (portal and femoral), use of the
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Seldinger percutaneous technique under ultrasono-
graphic guidance [13] and the technique introduced
by Oken et al. in 1994 to access the inflow vein
through internal jugular or subclavian veins [14]
without performing surgical cut-downs. This techni-
que reduced the incidence of complications associated
with open dissection of the axilla, including seroma
and lymphocele formation, wound infection, throm-
bosis and nerve injury [15].
With the introduction of the piggyback technique of
liver transplantation (PLTx) by Calne et al. in 1968
[16] and routine clinical use by Tzakis 20 years later
[17], as well as modification of the technique by
Belghiti et al. in 1992 [18], partial IVC clamping with
preservation of venous return provided the possibility
of a very selective use or avoidance of VVB [1921].
During LTx, the portal vein of the recipient has to be
clamped, which can lead to severe intestinal conges-
tion resulting in disruption of the intestinal mucosal
barrier, bacterial translocation, bacteremia, septic
complications and multiorgan failure. A temporary
portosystemic shunt was therefore needed [22]. For
this reason, Belghiti et al. modified their technique
with the use of a temporary porto-caval shunt to
preserve portal flow and to maintain splanchnic
venous drainage [12,23]. During recent decades, a
great diversity among centers in using VVB during
CLTx, or even applying it along with the PLTx
technique, has led to confusion regarding the indica-
tion settings for use of VVB during LTx. We therefore
present an overview of the use of VVB in patients
undergoing CLTx or PLTx.
Impact of VVB on liver transplantation
In early experiences of CLTx without VVB, mortality
and morbidity were high due to hemodynamic in-
stability resulting from complete cross-clamping of
IVC and the portal vein. The rationale for using VVB
during CLTx was to maintain hemodynamic stability,
to preserve cardiac, pulmonary, cerebral, renal and
intestinal flow and function, to reduce the need for
blood transfusion, to provide a longer anhepatic phase
for better surgical performance, and to improve
patient survival. The only contraindication for using
VVB was reported to be Budd-Chiari syndrome [9].
Studies on the effectiveness of VVB in LTx have
shown that the routine use of VVB varies widely
across institutions [24], categorizing them into three
groups. Some centers never use VVB, claiming that
performing the PLTx technique obviates the need for
VVB in all circumstances. Some use VVB only in
selected patients based on their surgical conditions,
preferably in the event of fulminant hepatic failure
(FHF), severe portal hypertension, volume overload,
or in patients who cannot tolerate the test cross-clamp
of the IVC intra-operatively [25]. The third group
comprises centers that perform CLTx routinely and
advocate the application of VVB [26]. The LTx
technique varies among transplant centers between
routine and selective use of IVC preservation [27],
between temporary portocaval shunt and VVB use
and non-use [20,28], and between different types of
anastomosis [29,30]. This has led to a variable
application setting among centers, including avoid-
ance and using VVB routinely or selectively.
During recent years, some few data have been
presented in support of any substantial improvements
in the above-mentioned factors following the use of
VVB in CLTx. However, advancements in transplant
anesthesiology, technical refinements of the LTx
procedure, and improvements in surgical skills have
led to CLTx being performed without VVB, and with
an acceptable long-term outcome. Additionally, ser-
ious side effects due to the use of VVB (reaching 10
30%) have limited its use at many transplant centers
[27]. Nevertheless, even with the introduction of
PLTx leading to avoidance of VVB at many transplant
centers, there are still transplant surgeons who per-
form CLTx with the use of VVB routinely or
selectively.
Venovenous bypass in CLTx
Different studies in CLTx have shown that the main
proposed indications for using VVB are hemodynamic
instability following test clamping of the IVC, im-
paired cardiac and renal function, fulminant hepatic
failure (FHF), severe portal, massive bleeding during
hepatectomy due to severe portal hypertension, and in
cases with familial amyloidotic polyneuropathy during
hepatectomy [15,27,3137]. Proposed indications
and their presumed pros and cons for the use of
VVB are summarized in Table I, and claimed advan-
tages and disadvantages of its use by different authors
in Table II.
Regarding hemodynamic instability following IVC
test clamping, Veroli et al. advocated the use of VVB
in patients with 30% drop in mean arterial pressure
and 50% decrease in cardiac index during a 5 min
test-clamping period [34]. However, several studies
have failed to show any increased rate of morbidity or
mortality in these patients with or without the use of
VVB [38,39]. Although cross-clamping of both portal
and IVC veins reduces the venous return and cardiac
output to 50%, the severity of hemodynamic instabil-
ity depends on the preload status before cross-clamp-
ing, the presence of underlying cardiovascular disease,
and the extent of collateral veins [12]. In patients with
normal cardiac status, the compensatory mechanisms,
such as increase in heart rate and vascular resistance,
may partially overcome this problem [38]. Further-
more, administration of vasopressors and strict vo-
lume adjustment can help to maintain preload and
hemodynamic stability without an increased risk of
volume overload and pulmonary edema following
reperfusion of the liver [15,40,41]. Meanwhile, the
majority of patients undergoing LTx have liver
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cirrhosis with well-developed portal venous collat-
erals; the effect of portal clamping on hemodynamic
status is therefore marginal [12]. However, Shaw et al.
stated that the presence of portal hypertension does
not necessarily protect patients from hemodynamic
instability [10] and some authors have advocated the
use of VVB in the event of severe portal hypertension
[15]. The rationale has been that large varices,
especially in the retrohepatic area, can cause severe
bleeding during hepatectomy.
Cardiopulmonary disorders, including pulmonary
hypertension, ventricular dysfunction, myocardial in-
farction, ischemic heart disease and cardiomyopathy,
have been proposed as indications for VVB [41,46
48]. However, several studies have shown that appli-
cation of VVB still decreases cardiac output and
increases systemic vascular resistance with little or
no change in cardiac filling pressure [49,50]. Further-
more, one study reported that with intravascular
volume expansion using a rapid-infusion device the
VVB could be avoided [48]. Therefore, the role of
VVB for cardiac protection remains controversial.
One of the most challenging parts of VVB is
preservation of renal function during the CLTx. In a
retrospective study by Shaw et al., the VVB led to
lower creatinine levels 3 days after LTx and a
decreased rate of post-LTx hemodialysis compared
with patients in whom VVB was not used [11]. In
contrast, later studies showed that in patients with
pretransplantation normal renal function, cross-
clamping of the IVC without the use of VVB did
not lead to renal dysfunction [34,49]. However, in
patients with prior impaired kidney function, there is a
diversity among authors, some advocating the use of
VVB [49,51,52], others not showing any significant
difference in terms of renal function [53,54]. Johnson
et al. found no substantial changes in peri- and
postoperative renal function and in short-term survi-
val when VVB was not used [53]. Another study has
shown that the use of VVB, the presence of post-
reperfusion syndrome (PRS), and transfusion of fresh
frozen plasma were the risk factors for renal failure in
CLTx [55].
Table I. Overview of proposed indications for the use of VVB during LTx.
Proposed indications for the use of VVB Pros for using VVB Cons for using VVB
Hemodynamic instability during test Chari et al. [27] Schwarz et al. [38]
cross-clamping of the vena cava inferior Veroli et al. [34] Wall et al. [33]
Impaired cardiac function such as
pulmonary hypertension Chari et al. [27]
impaired ventricular function Gifford et al. [46] Hilmi et al. [12]
myocordial infarction Beltran et al. [47]
ischemic heart diseasecardiomyopathy Stock et al. [48]
Renal dysfunction Shaw et al. [9] Wall et al. [52]
Grande [49] Johnson et al. [53]
Estrin et al. [51] Corti et al. [54]
Cabezuelo et al. [55]
Fulminant hepatic failure (FHF) Shaw et al. [11] Pere et al. [56]
Belghiti et al. [80] Prager et al. [57]
Wojcicki et al. [81]
Steib et al. [82]
Severe portal hypertension Reddy et al. [15] Belghiti et al. [80]
Severe bleeding during hepatectomy Shaw et al. [9] Fan et al. [42]
Chari et al. [27] Johnson et al. [53]
Wall et al. [33] Stegall et al. [83]
Table II. Claimed advantages and disadvantages of using VVB
during LTx.
Claimed advantages of using VVB References
- Maintaining the cerebral flow, especially in
FHF cases
9
- Preserving the cardiac and pulmonary flow 9
- Maintaining the renal flow and kidney
function
49
- Maintaining hemodynamic stability during
the anhepatic phase
9, 27, 34, 84
- Providing longer anhepatic phase for better
surgical performance
9
- Reduction of intraoperative blood loss 9, 34
- Improving the clinical outcome 9, 34
Claimed disadvantages of using VVB
- Pulmonary or air emboli, thrombosis 9, 15, 27
- No evidence of maintaining normal
perfusion of abdominal organs
27
- No evidence on preserving renal function 38, 39, 49, 55, 83
- Longer operative and warm ischemia time 42, 83
- Higher rate of post-reperfusion syndrome 37, 51, 58
- Hypothermia 15, 85
- Risk of bleeding due to the hemolysis and
fibrinolysis in bypass tubes
35
- Nerve injury, lymphocele, hematoma,
wound infection
9, 15, 27
- No evidence for improving the clinical
outcome
38, 39, 49, 56, 74,
76, 83
- Higher transplant cost 12, 35
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To maintain cerebral perfusion, several authors
argue for the use of VVB, especially in the event of
FHF. These reports indicate that 75% of patients with
FHF develop cerebral edema during CLTx. The
postulated causative factor reported was the lack of
an adequate collateral venous system leading to severe
hemodynamic instability. Consequently, owing to
cerebral blood flow impairment volume substitution
is needed to compensate for the hemodynamic
instability, which can result in fluid overload and
cerebral edema. Moreover, release of carbon dioxide
during reperfusion of the liver may lead to cerebral
vasodilatation and increasing intracranial pressure
[15]. Therefore, some surgeons have suggested the
routine use of VVB in patients with FHF. Never-
theless, there are authors who have shown that
cerebral perfusion can be preserved by careful and
adequate anesthesiological management without the
use of VVB in such patients [56,57].
PRS, first described by Aggarwal et al. in 1987 [58],
is a syndrome of cardiovascular collapse related to
systemic vasodilatation due to the release of vasoactive
substances from the reperfused liver, acidosis, hyper-
kalemia, hypercarbia and hypothemia [37,58,59]. The
definition was then refined by Estrin et al. as
bradycardia, ventricular dysfunction, and mean arter-
ial pressure below 60 mm Hg in adults, and below 50
mm Hg in children after liver reperfusion [51]. It has
been shown that the use of VVB is associated with an
increased rate of PRS to 30% and the rate of PRS in
patients without VVB was 3.73.8% [37,51,58]. In a
study by Zaballos et al., avoidance of VVB was
associated with a decreased incidence of PRS [37].
They speculated that lower serum kalium value in
patients without VVB might have contributed to lower
rate of PRS in these patients.
Morbidity of the VVB technique
Overall incidence of complications due to the use of
VVB is reported to be between 10% and 30% [27].
VVB can lead to fatal complications, such as decan-
nulation of the bypass circuit and air or thrombotic
pulmonary emboli. Other side effects include hy-
pothermia, blood clotting in the bypass system and
vessel thrombosis, lymphocele formation, hematoma,
vascular and nerve injury as a complication of catheter
placement, wound infection or dehiscence, infected
vascular suture lines, hemothorax after insertion of a
large bore cannula percutaneously, and prolonged
operative and warm ischemia time [15]. It has been
shown that hypothermia has deleterious effects on
myocardial functioning and hemodynamic status.
Some authors suggest that the use of a heat exchanger
is a good option, but that this can increase the
incidence of pulmonary embolism [12]. There are a
few reports indicating that VVB is associated with an
increased rate of red blood cells transfusion (15 vs. 8
units without VVB) due, presumably, to fibrinolysis,
hemolysis and bypass-mediating platelet adhesion
[4245]. In contrast, Kuo et al. have pointed out
that the absolute amount of administered blood
products was no different between the groups using
or avoiding the VVB [35]. In published studies, the
morbidity of VVB was similar in the two groups with
routine or selective use of VVB, i.e. 13.4% and
18.8%, respectively [27].
Regarding outcome following the use of VVB,
although Shaw et al. showed an improved 30-day
survival in patients who underwent CLTx with VVB,
some authors have not been able to demonstrate
better short-term or long-term outcome when this
technique was not used routinely [53]. In contrast,
selective use of VVB has shown significantly better
1-year patient survival than is the case in patients in
whom the VVB is used routinely. Chari et al. reported
that the outcome of CLTx was not influenced by the
policy of routine or selective use of VVB [27]. Table
III gives an overview of the controversies regarding the
claimed advantages of using the VVB during LTx as
reported by different transplant centers.
Venovenous bypass in PLTx
Introduction of the PLTx technique as an IVC
preserving procedure led to a limited need for VVB
in the majority of transplant cases [60]. Nonetheless,
some centers still use VVB in such patients because of
partial venous obstruction resulting from side-clamp-
ing of the IVC leading to intestinal congestion and
increased risk of instability after declamping as well as
bacterial translocation [15]. In fact, the unwillingness
to use PLTx without VVB or temporary passive shunt
at some small transplant centers is mainly due to their
fear of venous complications without the use of VVB
[61,62]. Moreover, they believe that with the use of
meticulous approaches, e.g. precise management of
volume and electrolyte substitution in recipients,
having the opportunity to put the venous dialysis
system on the circuit, using the Seldinger technique
for percutaneous cannulation of inflow veins, and
active warming during the extra-corporeal circulation,
this procedure can be a safe option for preventing
renal dysfunction and for maintaining normothermia
as well as a normal blood and electrolyte balance in
transplanting patients [26]. Nevertheless multicenter
studies show that PLTx can be performed with a low
incidence of hepatic venous complications [63].
Problems of anastomotic stenoses or thromboses
using the hepatic venous cuff can be overcome by
making a large latero-lateral anastomosis, the so-
called modified PLTx technique of Belghiti [18].
Moreover, outflow complications can be managed
with surgical [64] or interventional radiological pro-
cedures [65]. The IVC-preserving technique without
VVB can also be performed in the vast majority of re-
transplantations [66], because the plane between the
previous donor’s IVC and allograft may be more
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Table III. Controversies regarding the claimed advantages of using VVB during LTx.
Controversies regarding the claimed advantages for using VVB
Authors
Hemodynamic
stability
Cardiac
function Renal function Cerebral blood flow Pulmonary function Transfusion
Surgical
exposure Outcome
Shaw et al. [9,11]      ¡  
Veroli et al. [34]    in preoperative normal function
l in preoperative renal dysfunction
n/a n/a ¡ n/a 
Schwarz et al. [38] l  l n/a n/a n/a n/a l
Wall et al. [39]   l n/a n/a ¡ n/a l
Cheema et al. [41] l l n/a n/a n/a n/a n/a n/a
Fan et al. [42] ¡ n/a ¡ n/a ¡   operative time ¡
Grande et al. [49]   l n/a  l n/a l
Cabezuelo et al. [55] n/a n/a ¡ versus PLTx n/a n/a n/a n/a n/a
Pere et al. [56] l  n/a l n/a n/a n/a l
Prager et al. [57] n/a n/a n/a l n/a n/a n/a n/a
Jovine et al. [69] l n/a ¡ versus PLTx n/a n/a l versus PLTx l operative time l versus PLTx
Isern et al. [74] n/a n/a n/a n/a l
¡ infiltrates vs. PLTx
l versus PLTx n/a l versus PLTx
Golfieri et al. [75] n/a n/a n/a n/a ¡ noninfection complications
vs. PLTx
n/a n/a n/a
Carvalho et al. [76] n/a n/a n/a n/a l
¡ infiltrates vs. PLTx
n/a n/a l versus PLTx
Stegall et al. [83]   l  intracranial pressure ¡ l  operative time l
Shokouh-Amiri et al. [86] l n/a l versus PLTx n/a n/a  versus PLTx  operative time ¡ versus PLTx
Khan et al. [87] l n/a l versus PLTx n/a  ventilatory support vs. PLTx  versus PLTx l operative time l versus PLTx
2
0
0
H
.
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accessible [67,68]. The advantages of the PLTx
technique without VVB are summarized in Table IV
[6972].
It has been shown that the cardiac function can be
preserved during PLTx even without the use of
temporary portosystemic shunt. Moreover, there is
less renal flow disturbance due to partial preservation
of IVC flow. PLTx has also been shown to decrease
the warm ischemia time [70], anhepatic phase,
operating time [61], and hospital stay [73]. Further-
more, the PLTx technique has been attributed with
better tissue perfusion attenuating the risk of cerebral
perfusion problems. Regarding the rate of pulmonary
complications, a study by Isern et al. showed no
significant differences between CLTx with VVB and
PLTx without VVB, but other studies noted that
extensive fluid administration in PLTx with the
absence of VVB on one side and bacterial transloca-
tion because of portal clamping on the other led to a
higher trend of complications, including pneumonia,
pulmonary edema and infiltrates, atelectasis, and
pleural effusion, which could subside by precise
volume optimization as well as performing temporary
porto-systemic shunts [7477]. Nevertheless, there
were no significant differences regarding pulmonary
gas exchange, pulmonary compliance, duration of
mechanical ventilation, length of hospital stay, or
patient mortality [74].
It can be speculated that CLTx without VVB has a
similar hemodynamic condition compared to CLTx
with use of VVB [32,66,78]. Additionally, there are no
significant differences in perioperative parameters,
postoperative renal function, or short-term survival
when surgeons do not use VVB [53]. Avoiding VVB
also decreases the need for excessive fluid adminis-
tration and prolonged ventilatory assistance in the
majority of cases [79]. Furthermore, the extra cost of
VVB and the presence of more effective and cost-
benefit procedures such as PLTx have limited appli-
cation of the VVB to only highly selective cases in
which using VVB provides better surgical exposure or
in cases in which its avoidance may be life-threatening
[12] such as in cases of FHF or severe portal
hypertension.
Conclusions
In summary, there are some proposed theoretical
benefits of using VVB that could not be constantly
demonstrated in different studies. Although the use of
VVB is still under debate among transplant centers,
many centers have realized that due to the higher rate
of complications with VVB and continuous advance-
ments in surgical techniques as well as anesthesia, its
routine use is no longer necessary. At present, only a
few transplant centers still use VVB as a standard
approach. With popularization of the PLTx techni-
que, VVB has been abolished or limited to selected
cases. The PLTx procedure can be performed in
nearly all primary recipients and in the majority of re-
transplantations. Finally, avoiding VVB or using it as a
routine or selective approach is based on the surgical
experience of the transplant team and each centre’s
preferences.
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